NHS Patient Safety Technology Provider Patientrack Becomes Alcidion

Alcidion LtdA technology company that has helped NHS hospitals in England and Scotland to quickly identify and respond to their sickest patients, will now be known as Alcidion. Patientrack, which is known for providing technology for electronic patient observations and early warnings of patient deterioration to the NHS, first announced it had been acquired by Alcidion Group Limited in 2018.

The company's product - also called Patientrack - will still be available to NHS hospitals, which have recordedsignificant gains in patient safety by using the technology - including reductions in cardiac arrests, mortality, lengths of stay, and admissions to intensive care. Hospitals have also innovated with the Patientrack technology to tackledeadly conditions, including acute kidney injury and sepsis.

Whilst the Patientrack product will remain fully supported with the same dedicated UK team, the company has now been formally rebranded as Alcidion, to reflect its wider offering of cutting edge technology to the NHS, designed to transform healthcare.

Donald Kennedy, UK general manger, Alcidion, said: “We are building on a remarkable legacy of collaboration with the NHS that has delivered a big impact on patient safety.

"As Alcidion, we have the ability to take this to the next level, and to offer the NHS a much wider set of digital tools. These have been designed to not only support the next generation of patient safety, but to streamline patient journeys, increase operational efficiency, inform clinical decision making and help hospitals to understand their data.

"We are already doing all of this with early NHS pioneers, and so it is only fitting that we adopt our new identity that reflects our even more compelling offer to the NHS."

Dartford and Gravesham NHS Trust became the first UK organisation to procure the full Alcidion product suite in a five-year partnership announced earlier in 2019. The trust is deploying ahealth technology platformthat will transform patient safety and clinical efficiency for its hospitals and its local healthcare system partners and will help the trust realise its mission to become a self-made digital exemplar.

Alcidion provides solutions spanning predictive analytics, patient flow, clinical messaging, integration support, and clinical decision making. The Patientrack product will continue to perform its electronic observations, patient assessments and early warning role, as part of an integrated offering with other Alcidion products. This includes the Miya platform, which provides decision intelligence software that consolidates real-time data from disparate healthcare IT systems and pushes decision intelligence and guidance to users via mobile devices.

The Miya platform is cloud based with analytics tools to help professionals manage clinical workflows and reduce avoidable injury. It provides logistics tools to give valuable time back to the care team.

Smartpage, the company's clinical messaging system is used in hospitals to improve communication and safety in the clinical environment.

Kate Quirke, managing director of Alcidion, said: "This is about transforming healthcare together, by empowering doctors and nurses to deliver the best possible outcomes for their patients. We are already working with the NHS to use technology in a way that delivers insights to clinicians so they can prevent and intervene.

"Healthcare professionals need to understand how their patients are progressing and need to have information about their current status and potential risk. Alcidion has rapidly developed in the last 12 months in meeting these challenges, with acquisitions allowing us to grow into a leading informatics company helping healthcare providers throughout the world.

"People in the NHS have come to know Patientrack as an important innovator in the patient safety arena, and we now look forward to developing that innovation to a growing number of areas, as we continue to partner with one of the most respected health institutions in the world to deliver the best for its patients."

About Alcidion Ltd

Alcidion Ltd (ASX:ALC) has a simple purpose, that is, to make healthcare better with smart, intuitive solutions that meet the needs of hospital and allied healthcare, worldwide. Alcidion incorporates three healthcare software companies previously known as Alcidion Corporation, Patientrack and Smartpage, and MKM Health, an IT solutions and services provider. Each company brings a complementary set of products and skills that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. With over 25 years of combined healthcare experience, the Alcidion Group of companies brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...